Consainsights logo
Reports > Life Sciences > Ophthalmic Viscosurgical Devices Market Report

Ophthalmic Viscosurgical Devices Market Size, Share, Industry Trends and Forecast to 2033

This report provides an in-depth analysis of the Ophthalmic Viscosurgical Devices market from 2023 to 2033, offering key insights into market size, growth rates, industry analysis, segmentation, technological advancements, and regional breakdowns.

Metric Value
Study Period 2023 - 2033
2023 Market Size $2.10 Billion
CAGR (2023-2033) 6.8%
2033 Market Size $4.13 Billion
Top Companies Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson Vision, Carl Zeiss AG, Abbott Laboratories
Last Modified Date 15 Nov 2024

Ophthalmic Viscosurgical Devices Market Report (2023 - 2033)

Ophthalmic Viscosurgical Devices Market Overview

The ophthalmic viscosurgical devices industry is characterized by a competitive landscape featuring various global and regional players. This industry is experiencing notable technological advancements, focusing on product innovations that enhance patient outcomes. Regulatory considerations by authorities such as the FDA and CE mark play a pivotal role in determining market dynamics and the entry of new products. Furthermore, the demand for minimally invasive surgical techniques is influencing product development, leading to the introduction of advanced OVDs that are tailored for specific surgical applications. The interplay between rising healthcare expenditure, growth in ophthalmic surgeries, and an increasing focus on professional training in eye care is expected to drive the market significantly.

What is the Market Size & CAGR of Ophthalmic Viscosurgical Devices market in 2023?

The ophthalmic viscosurgical devices market size in 2023 is estimated to be approximately USD 3.08 billion. With a projected compound annual growth rate (CAGR) of around 8.5%, the market is expected to grow significantly, reaching approximately USD 5.64 billion by 2033. Key drivers of this growth include the increasing number of cataract and glaucoma surgeries, rising geriatric population, and advancements in surgical equipment and interventions. The need for effective surgical solutions and the growing awareness of eye health are additionally boosting market demand.

Ophthalmic Viscosurgical Devices Industry Analysis

The ophthalmic viscosurgical devices industry is characterized by a competitive landscape featuring various global and regional players. This industry is experiencing notable technological advancements, focusing on product innovations that enhance patient outcomes. Regulatory considerations by authorities such as the FDA and CE mark play a pivotal role in determining market dynamics and the entry of new products. Furthermore, the demand for minimally invasive surgical techniques is influencing product development, leading to the introduction of advanced OVDs that are tailored for specific surgical applications. The interplay between rising healthcare expenditure, growth in ophthalmic surgeries, and an increasing focus on professional training in eye care is expected to drive the market significantly.

Ophthalmic Viscosurgical Devices Market Segmentation and Scope

The ophthalmic viscosurgical devices market can be segmented based on product type, application, and end-user. Key product types include hyaluronic acid-based and non-hyaluronic acid-based OVDs. The primary applications encompass cataract surgery, corneal surgery, glaucoma surgery, and vitreoretinal surgery. Hospitals, ophthalmic clinics, and surgical centers constitute the main end-users. The scope of this market extends to various regions, reflecting the diverse adoption of technologies and techniques, with significant variations in market size attributable to regional healthcare infrastructure, economic conditions, and demographics.

Request a custom research report for industry.

Ophthalmic Viscosurgical Devices Market Analysis Report by Region

Europe Ophthalmic Viscosurgical Devices Market Report:

The European market is estimated at USD 0.57 billion in 2023, with a projected size of USD 1.11 billion by 2033. Increased governmental healthcare initiatives, a growing aging population, and advanced surgical techniques support market expansion in Europe.

Asia Pacific Ophthalmic Viscosurgical Devices Market Report:

In the Asia Pacific region, the market size in 2023 is estimated at USD 0.42 billion and is projected to grow to USD 0.83 billion by 2033. The rise in ocular diseases, advancements in healthcare facilities, and increased purchasing power among the population are key factors driving market growth in this region.

North America Ophthalmic Viscosurgical Devices Market Report:

In North America, the market size is expected to expand from USD 0.78 billion in 2023 to USD 1.53 billion by 2033. The high prevalence of eye disorders and strong market players contribute to the robust growth, along with continuous innovations and high healthcare expenditure.

South America Ophthalmic Viscosurgical Devices Market Report:

The South American market for ophthalmic viscosurgical devices is anticipated to grow from USD 0.15 billion in 2023 to USD 0.30 billion by 2033. This growth is attributed to increasing awareness of eye health, coupled with enhancements in ocular healthcare systems across countries in the region.

Middle East & Africa Ophthalmic Viscosurgical Devices Market Report:

The market in the Middle East and Africa is expected to see growth from USD 0.18 billion in 2023 to USD 0.36 billion by 2033. This growth can be attributed to the expansion of healthcare infrastructure and rising health awareness regarding eye health.

Request a custom research report for industry.

Ophthalmic Viscosurgical Devices Market Analysis By Product Type

Global Ophthalmic Viscosurgical Devices Market, By Product Type Market Analysis (2023 - 2033)

The ophthalmic viscosurgical devices market primarily consists of hyaluronic acid-based products, which dominate the market with a share of 87.87% in 2023, expected to grow to 87.87% by 2033. Non-hyaluronic acid products represent a smaller segment, constituting 12.13% of the market in 2023. The preference for hyaluronic acid products in various surgical procedures reflects their superior performance in maintaining viscoelastic properties.

Ophthalmic Viscosurgical Devices Market Analysis By Application

Global Ophthalmic Viscosurgical Devices Market, By Application Market Analysis (2023 - 2033)

Cataract surgery occupies the largest market share in the application category, where it holds 50.52% in 2023, expected to persist through 2033. Corneal and glaucoma surgeries represent significant growth segments, with respective shares of 24.61% and 11.84%. The increasing rate of these surgeries enhances demand for ophthalmic viscosurgical devices across these applications.

Ophthalmic Viscosurgical Devices Market Analysis By End User

Global Ophthalmic Viscosurgical Devices Market, By End-User Market Analysis (2023 - 2033)

Hospitals are the dominant end-user segment, contributing 60.72% to the market in 2023 and anticipated to remain steady. Ophthalmic clinics, representing 24.73% in 2023, and surgical centers at 14.55% are also vital stakeholders, reflecting varies preferences for access to surgical resolutions.

Ophthalmic Viscosurgical Devices Market Analysis By Region Type

Global Ophthalmic Viscosurgical Devices Market, By Region Type Market Analysis (2023 - 2033)

The global distribution of the ophthalmic viscosurgical devices market reveals significant differences among regions. North America leads with considerable market size, followed closely by Europe, Asia Pacific, and South America. Each regional market dynamically influenced by varying economic development, demographic factors, and levels of healthcare expenditure.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Ophthalmic Viscosurgical Devices Industry

Alcon Inc.:

A leading provider of innovative eye care products, Alcon specializes in surgical devices and contact lenses, focusing on enhancing patient experience and outcomes.

Bausch Health Companies Inc.:

Bausch Health offers a comprehensive portfolio of ophthalmic products, including surgical devices, and is recognized for its commitment to innovation and advancing eye health.

Johnson & Johnson Vision:

This company offers a broad range of vision care solutions, with strong emphasis on surgical products, dedicated to optimizing surgical experiences in ophthalmic procedures.

Carl Zeiss AG:

Carl Zeiss is renowned for precision optics and specializes in ophthalmic devices, focusing on improvements in surgical technology through innovative solutions.

Abbott Laboratories:

Abbott provides various medical devices, including ophthalmic devices, and is committed to enhancing patient care through cutting-edge technologies.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs